<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Br J Clin Pharmacol</journal-id><journal-id journal-id-type="iso-abbrev">Br J Clin Pharmacol</journal-id><journal-id journal-id-type="pmc-domain-id">279</journal-id><journal-id journal-id-type="pmc-domain">brjclinpharm</journal-id><journal-id journal-id-type="publisher-id">bcp</journal-id><journal-title-group><journal-title>British Journal of Clinical Pharmacology</journal-title></journal-title-group><issn pub-type="ppub">0306-5251</issn><issn pub-type="epub">1365-2125</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC3477348</article-id><article-id pub-id-type="pmcid-ver">PMC3477348.1</article-id><article-id pub-id-type="pmcaid">3477348</article-id><article-id pub-id-type="pmcaiid">3477348</article-id><article-id pub-id-type="pmid">22300396</article-id><article-id pub-id-type="doi">10.1111/j.1365-2125.2012.04205.x</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Pharmacokinetics</subject></subj-group></article-categories><title-group><article-title>Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Svensson</surname><given-names initials="E">Elin</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>van der Walt</surname><given-names initials="JS">Jan-Stefan</given-names></name><xref ref-type="aff" rid="au1">1</xref><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Barnes</surname><given-names initials="KI">Karen I</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Cohen</surname><given-names initials="K">Karen</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kredo</surname><given-names initials="T">Tamara</given-names></name><xref ref-type="aff" rid="au2">2</xref><xref ref-type="aff" rid="au3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Huitema</surname><given-names initials="A">Alwin</given-names></name><xref ref-type="aff" rid="au4">4</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Nachega</surname><given-names initials="JB">Jean B</given-names></name><xref ref-type="aff" rid="au2">2</xref><xref ref-type="aff" rid="au5">5</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Karlsson</surname><given-names initials="MO">Mats O</given-names></name><xref ref-type="aff" rid="au1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Denti</surname><given-names initials="P">Paolo</given-names></name><xref ref-type="aff" rid="au2">2</xref></contrib><aff id="au1"><label>1</label><institution>Department of Pharmaceutical Bioscience, Uppsala University</institution><addr-line>Uppsala, Sweden</addr-line></aff><aff id="au2"><label>2</label><institution>Department of Medicine, Division of Clinical Pharmacology, University of Cape Town</institution><addr-line>Cape Town</addr-line></aff><aff id="au3"><label>3</label><institution>South African Cochrane Centre, South African Medical Research Council</institution><addr-line>Western Cape, Cape Town, South Africa</addr-line></aff><aff id="au4"><label>4</label><institution>Department of Pharmacy &amp; Pharmacology, Slotervaart Hospital</institution><addr-line>Amsterdam, The Netherlands</addr-line></aff><aff id="au5"><label>5</label><institution>Johns Hopkins University, Bloomberg School of Public Health</institution><addr-line>Baltimore, MD, USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1">Ms Elin Svensson MSc, Department of Pharmaceutical Bioscience, Uppsala University, PO Box 591, 751 24 Uppsala, Sweden. Tel.: +46 18 4714418. Fax: +46 18 4714003. E-mail: <email>elin.svensson@farmbio.uu.se</email></corresp></author-notes><pub-date pub-type="ppub"><month>9</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>02</day><month>2</month><year>2012</year></pub-date><volume>74</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">215557</issue-id><fpage>465</fpage><lpage>476</lpage><history><date date-type="received"><day>04</day><month>11</month><year>2011</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2012</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>09</month><year>2013</year></date></event><event event-type="pmc-live"><date><day>01</day><month>09</month><year>2013</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2013-09-01 00:13:39.083"><day>01</day><month>09</month><year>2013</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2012 The British Pharmacological Society</copyright-statement><copyright-year>2012</copyright-year></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="bcp0074-0465.pdf"/><abstract><sec><title>AIMS</title><p>To propose a modelling strategy to efficiently integrate data from different sources in one simultaneous analysis, using nevirapine population pharmacokinetic data as an example.</p></sec><sec><title>METHODS</title><p>Data from three studies including 115 human immunodeficiency virus-infected South African adults were used. Patients were on antiretroviral therapy regimens including 200 mg nevirapine twice daily and sampled at steady state. A development process was suggested, implemented in NONMEM7 and the final model evaluated with an external data set.</p></sec><sec><title>RESULTS</title><p>A stepwise approach proved efficient. Model development started with the intensively sampled data. Data were added sequentially, using visual predictive checks for inspecting their compatibility with the existing model. Covariate exploration was carried out, and auxiliary regression models were designed for imputation of missing covariates. Nevirapine pharmacokinetics was described by a one-compartment model with absorption through two transit compartments. Body size was accounted for using allometric scaling. The model included a mixture of two subpopulations with different typical values of clearance, namely fast (3.12 l h<sup>&#8722;1</sup>) and slow metabolizers (1.45 l h<sup>&#8722;1</sup>), with 17% probability of belonging to the latter. Absorption displayed large between-occasion variability, and food slowed the absorption mean transit time from 0.6 to 2.5 h. Concomitant antitubercular treatment including rifampicin typically decreased bioavailability by 39%, with significant between-subject variability. Visual predictive checks of external validation data indicated good predictive performance.</p></sec><sec><title>CONCLUSIONS</title><p>The development strategy succeeded in integrating data from different sources to produce a model with robust parameter estimates. This work paves the way for the creation of a nevirapine mega-model, including additional data from numerous diverse sources.</p></sec></abstract><kwd-group><kwd>missing covariates</kwd><kwd>nevirapine</kwd><kwd>NONMEM</kwd><kwd>population pharmacokinetics</kwd><kwd>prediction and variability corrected visual predictive check</kwd><kwd>simultaneous modelling analysis</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>